BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Qu CY, Zhang FY, Wang W, Gao FY, Lin WL, Zhang H, Chen GY, Zhang Y, Li MM, Li ZH, Cai MH, Xu LM, Shen F. Endoscopic polidocanol foam sclerobanding for the treatment of grade II-III internal hemorrhoids: A prospective, multi-center, randomized study. World J Gastroenterol 2024; 30(27): 3326-3335 [PMID: 39086750 DOI: 10.3748/wjg.v30.i27.3326]
URL: https://www.wjgnet.com/1007-9327/full/v30/i27/3326.htm
Number Citing Articles
1
An-Na Mou, Yu-Ting Wang. Endoscopic polidocanol foam sclerobanding for treatment of internal hemorrhoids: A novel outpatient procedureWorld Journal of Gastroenterology 2024; 30(42): 4583-4586 doi: 10.3748/wjg.v30.i42.4583
2
PolidocanolReactions Weekly 2024; 2026(1): 282 doi: 10.1007/s40278-024-67145-8
3
Yu-Yan Zhang, Bing Hu. Endoscopic polidocanol foam sclerobanding for the treatment of Grade II-III internal hemorrhoids: The focus of clinical practiceWorld Journal of Gastroenterology 2024; 30(38): 4246-4248 doi: 10.3748/wjg.v30.i38.4246
4
Asad Gul Rao, Abdulqadir J Nashwan. Redefining hemorrhoid therapy with endoscopic polidocanol foam sclerobandingWorld Journal of Gastroenterology 2024; 30(36): 4021-4024 doi: 10.3748/wjg.v30.i36.4021